Monte Rosa Therapeutics
GLUE
#7806
Rank
A$0.40 B
Marketcap
$6.53
Share price
1.54%
Change (1 day)
-39.19%
Change (1 year)

Earnings for Monte Rosa Therapeutics (GLUE)

Earnings in 2024 (TTM): -A$0.11 Billion

According to Monte Rosa Therapeutics's latest financial reports the company's current earnings are A$75.62 Million. , an increase over its 2023 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monte Rosa Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.12 Billion-48.06%
2023 -A$0.23 Billion24.43%
2022 -A$0.18 Billion46.71%
2021 -A$0.13 Billion106.13%
2020 -A$59.35 Million